The world is looking to scientists and drug researchers to bring an end to the COVID-19 pandemic. FDA has authorized 20 test drug developers (and counting) to test possible treatments for the disease and science can look to the tech world to make their work easier. At a time like this, there’s the temptation to ignore certain systems in an endeavor to find an effective treatment or vaccine for the disease. Pharmacovigilance reporting, however, can’t be ignored or overlooked, we need to be sure that the drugs work and have no adverse effects.
This is where Windward comes into action when you’re looking for a faster way to report clinical trials and adverse events to get the drugs ready for use.
While the drug developers are busy trying to find that SARS-CoV-2 (Coronavirus) drug, they shouldn’t be burdened with gathering drug reaction and resistance data, taking down notes, and preparing reports manually. Consider reporting automation software like Windward as it will shave off a considerable amount of time spent on pharmacovigilance reporting. The best part is you can automate the whole reporting process in just a few clicks and let the software handle all those routine reporting tasks while you continue your research.
Windward helps drug developers compile and share pharmacovigilance reports fast. Less time is spent finding data and creating templates, unlike other reporting software in the industry that requires extensive coding and intense collaboration just to create report templates.
Windward reporting software can do all that with pre-approved or imported templates, unlimited parameters, conditional formatting (and more) so that reports can be prepared faster even by an individual researcher and passed on to the FDA and other regulatory bodies. This also helps drug developers in different countries collaborate as they collect pharmacovigilance data from different geographical locations. More on this below.
Drug developers and researchers can’t restrict their work to only their country (especially when it’s a pandemic), they need to collaborate with others around the world. You can share reports with your foreign peers in their language and local measurements with the help of Windward. The reporting software helps create reports in hundreds of languages, no wonder Windward is availed in over 70 countries globally.
If you consider the amount of time that goes into compiling pharmacovigilance reports, you realize that it directly contributes to delay in the release of vital drugs to fight pandemic diseases like COVID-19. Windward can hasten the reporting process without crossing the guidelines of pharmacovigilance and do more to further the goal of drug developers and above all in bringing back good health to the world.